Genome-wide association scan in psoriasis: New insights into chronic inflammatory disease

Expert Review of Clinical Immunology

Volumn 4, Issue 5, 2008, Pages 565-571

  Schrodi, Steven J ^a  

^a CELERA   (United States)

Author keywords

Genetic mapping; Genome wide association; Psoriasis; Psoriatic arthritis; Single nucleotide polymorphism

Indexed keywords

HLA C ANTIGEN; INTERLEUKIN 12P40; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR;

CHROMOSOME 1Q; CHRONIC INFLAMMATION; CROHN DISEASE; EPIDERMIS HYPERPLASIA; GENE EXPRESSION; GENE MAPPING; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; NOTE; PATHOGENESIS; PHARMACOGENETICS; PLEIOTROPY; PROGNOSIS; PSORIASIS; PSORIATIC ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; TH17 CELL;

EID: 77649103006     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/1744666X.4.5.565     Document Type: Note

References (50)

1. Liu Y, Helms C, Liao W et al. A genomewide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 4(3), e1000041 (2008).
2. Cargill M, Schrodi SJ, Chang M et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet. 80, 273-290 (2007).
3. Capon F, DiMeglio P, Szaub J et al. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum. Genet. 122, 201-206 (2007).
4. Kimmel G, Jordan MI, Halperin E, Shamir R, Karp RM. A randomization test for controlling population stratification in whole-genome association studies. Am. J. Hum. Genet. 81(5), 895-905 (2007).
5. Nair RP, Stuart PE, Nistor I et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am. J. Hum. Genet. 78(5), 827-851 (2006).
6. Varki A, Altheide TK. Comparing the human and chimpanzee genomes: searching for needles in a haystack. Genome Res. 15, 1746-1758 (2005).
7. Lesueur F, Oudot T, Heath S et al. ADAM33, a new candidate for psoriasis susceptibility. PLoS ONE 2(9), e906 (2007).
8. Siroux V, Bouzigon E, Dizier MH et al. Replication of association between ADAM33 polymorphisms and psoriasis. PLoS ONE 3(6), e2448 (2008).
9. Van Eerdewegh P, Little RD, Dupuis J et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418, 426-430 (2002).
10. Friedmann E, Hauben E, Maylandt K et al. SPPL2a and SPPL2b promote intramembrane proteolysis of TNF-α in activated dendritic cells to trigger IL-12 production. Nat. Cell Biol. 8(8), 843-848 (2006).
11. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-683 (2007).
12. Todd JA, Walker NM, Cooper JD et al. Robust associations of four new chromosome regions from genome-wide analyses of Type 1 diabetes. Nat. Genet. 39, 857-864 (2007).
13. Van Heel DA, Franke L, Hunt KA et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat. Genet. 39, 827-829 (2007).
14. Zhernakova A, Alizadeh BZ, Bevova M et al. Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of Type 1 diabetes point to a general risk locus for autoimmune diseases. Am. J. Hum. Genet. 81, 1284-1288 (2007).
15. Zhou L, Ivanov II, Spolski R et al. IL-6 programs Th-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8(9), 967-974 (2007).
16. Zhang X-J, Yan K-L, Wang Z-M et al. Polymorphisms in interleukin-15 gene on chromosome 4q31.2 are associated with psoriasis vulgaris in Chinese population. J. Invest. Derm. 127, 2544-2551 (2007).
17. Becker KG, Simon RM, Bailey-Wilson JE et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc. Natl Acad. Sci. USA 95(17), 9979-9984 (1998).
18. Tsunemi Y, Saeki H, Nakamura K et al. Interleukin-12 p40 gene (IL12B) 3́-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J. Dermatol. Sci. 302, 161-166 (2002).
19. Marquet S, Doumbo O, Cabantous S et al. A functional promoter variant in IL12B predisposes to cerebral malaria. Hum. Mol. Genet. 17(14), 2190-2195 (2008).
20. Morahan G, Kaur G, Singh M et al. Association of variants in the IL12B gene with leprosy and tuberculosis. Tissue Antigens 69(Suppl. 1), 234-236 (2007).
21. Randolph AG, Lange C, Silverman EK et al. The IL12B gene is associated with asthma. Am. J. Hum. Genet. 75(4), 709-715 (2004).
22. Fisher SA, Tremelling M, Anderson CA et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat. Genet. 40(6), 710-712 (2008).
23. Yilmaz V, Demirbilek V, Gurses C et al. Interleukin (IL)-12, IL-2, interferon-γ gene polymorphisms in subacute sclerosing panencephalitis patients. J. Neurovirol. 13(5), 410-415 (2007).
24. Duerr RH, Taylor KD, Brant SR et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461-1463 (2006).
25. Cho JH. The genetics and immunopathogenesis of inflammatory bowel disease. Nat. Rev. Immunol. 8(6), 458-466 (2008).
26. Van Limbergen J, Russell RK, Nimmo ER et al. IL23R Arg381Gln is associated with childhood onset inflammatory bowel disease in Scotland. Gut 56, 1173-1174 (2007).
27. Burton PR, Clayton DG, Cardon LR et al.; Wellcome Trust Case Control Consortium, Australo-Anglo-American Spondylitis Consortium (TASC). Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet. 39, 1329-1337 (2007).
28. Huber AK, Jacobson EM, Jazdzewski K, Concepcion ES, Tomer Y. IL-23R is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/Th17 axis extends to thyroid autoimmunity. J. Clin. Endocrinol. Metab. 93, 1077-1081 (2007).
29. Jarvinen HJ, Aarnio M, Mustonen H et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118(5), 829-834 (2000).
30. van Roosmalen MS, Stalmeier PF, Verhoef LC et al. Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers. J. Clin. Oncol. 22(16), 3293-3301 (2004).
31. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: The Metabolic and Molecular Bases of Inherited Disease (8th Edition) (Volume 2). Scriver CR, Beaud AL, Sly WS, Valle D (Eds). McGraw-Hill, NY, USA 2863-2913 (2001).
32. Chang M, Li Y, Yan C et al. Variants in the 5q31 cytokine gene cluster are associated with psoriasis. Genes Immun. 9(2), 176-181 (2008).
33. Lee E, Trepicchio WL, Oestreicher JL et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J. Exp. Med. 199, 125-130 (2004).
34. Chan JR, Blumenschein W, Murphy E et al. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2- dependent mechanisms with implications for psoriasis pathogenesis. J. Exp. Med. 203, 2577-2587 (2006).
35. Ghilardi N, Kljavin N, Chen Q, Lucas S, Gurney AL, de Sauvage FJ. Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice. J. Immunol. 172, 2827-2833 (2004).
36. Park H, Li Z, Yang XO et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 (2005).
37. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123-1132 (2005).
38. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T-cells. Immunity 24, 179-189 (2006).
39. Hue S, Ahern P. Buonocore S et al. Interleukin-23 drives innate and T cellmediated intestinal inflammation. J. Exp. Med. 203, 2473-2483 (2006).
40. Kauffman CL, Aria N, Toichi E et al. A Phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis. J. Invest. Dermatol. 123, 1037-1044 (2004).
41. Krueger GG, Langley RG, Leonardi C et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N. Engl. J. Med. 356, 580-592 (2007).
42. Mannon PJ, Fuss IJ, Mayer L et al. Anti-interleukin-12 antibody for active Crohn's disease. N. Engl. J. Med. 351, 2069-2079 (2004).
43. Hollox EJ, Huffmeier U, Zeeuwen PL et al. Psoriasis is associated with increased β-defensin genomic copy number. Nat. Genet. 40, 23-25 (2008).
44. Begovich AB, Carlton VE, Honigberg LA et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75(2), 330-337 (2004).
45. White TJ, Clark AG, Broder S. Genomebased biomarkers for adverse drug effects, patient enrichment and prediction of drug response, and their incorporation into clinical trial design. Personalized Medicine 3(2), 177-185 (2006).
46. Pearson ER, Donnelly LA, Kimber C et al. Variation in TCF7L2 influences therapeutic response to sulfonylureas. Diabetes 56, 2178-2182 (2007).
47. Iakoubova OA, Tong CH, Rowland CM et al. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials. J. Am. Coll. Cardiol. 51(4), 435-443 (2008).
48. Shiffman D, Chasman DI, Zee RYL et al. A kinesin family member 6 variant is associated with coronary heart disease in the women's health study. J. Am. Coll. Cardiol. 51, 444-448 (2008).
49. Iakoubova OA, Sabatine MS, Rowland CM et al. Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes. J. Am. Coll. Cardiol. 51, 449-455 (2008).
50. Anderson CA, Pettersson FH, Barrett JC et al. Evaluating the effects of imputation on the power, coverage, and cost efficiency of genome-wide SNP platforms. Am. J. Hum. Genet. 83(1), 112-119 (2008).